1-4 of 4
Roger Herzig, MD
Close
Sort by
Journal Articles

The Experience in Treating Elders with AML Using High-Dose AraC.

Cesar Rodriguez, MD, Roger Herzig, MD, Geoffrey P. Herzig, MD
Journal: Blood
Blood (2016) 128 (22): 5201.
https://doi.org/10.1182/blood.V128.22.5201.5201
Published: 2016
Journal Articles

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Runa Shrestha, MD, Ahmad Al-Attar, MD, John W Hayslip, MD, Lutz T Charles, MD, Emily Dressler, PhD, Jabbour Hossam, MD, Maryam F Zia, MD, Hayder Saeed, MD, Amit Goldberg, MD, Gregory Monohan, MD, Roger Herzig, MD, Roger A Fleischman, MD, PhD, Gerhard Hildebrandt, MD, Shams A Shakil, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 5296.
https://doi.org/10.1182/blood.V128.22.5296.5296
Published: 2016
Journal Articles

Durable Chimerism, Absence of Graft-Versus-Host Disease and the Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Transplants and Therapeutic Cell Transfer

Joseph Leventhal, Michael Abecassis, M.D., Joshua Miller, M.D., Lorenzo Gallon, M.D., Kadiyala Ravindra, M.D., David J Tollerud, MD, MPH, Bradley J King, Geoffrey Herzig, M.D., Roger Herzig, MD, Suzanne T Ildstad, MD
Journal: Blood
Blood (2011) 118 (21): 832.
https://doi.org/10.1182/blood.V118.21.832.832
Published: 2011
Journal Articles

Phase II Trial of Prochymal™ (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) and Corticosteroids as Primary Treatment for Acute Graft-Vs-Host Disease (aGVHD).

Partow Kebriaei, MD, Luis Isola, MD, Erkut Bahceci, MD, H. Kent Holland, MD, Scott Rowley, MD, Joseph McGuirk, DO, Marcel Devetten, MD, Jan Jansen, MD, PhD, Roger Herzig, MD, Michael Schuster, MD, Joseph Uberti, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3231.
https://doi.org/10.1182/blood.V108.11.3231.3231
Published: 2006